ErvinR. F.BullockW. E.: Clinical and Pharmacological Studies of Ticarcillin in Gram-Negative Infections, Antimicrob. Agents Chemother.9: 94–101 (Jan.) 1976.
3.
ParryM. F.NeuH. C.: Pharmacokinetics of Ticarcillin in Patients with Abnormal Renal Function, J. Infect. Dis.133: 46–49 (Jan.) 1976.
4.
NeuH. C.WinshellE. B.: Semisynthetic Penicillin 6-[D(−)-α-Carboxy-3-Thenylacetamide] Penicillinic Acid Active Against Pseudomonas in Vitro, Appl. Microbiol.21: 66–79 (Jan.) 1971.
5.
LynnB.: Administration of Carbenicillin and Ticarcillin - Pharmaceutical Aspects, Eur. J. Cancer9: 425–433 (June) 1973.
6.
PriorR. B.WarnerJ. F.: Morphological Alteration of Pseudomonas aeruginosa by Ticarcillin: A Scanning Electron Microscope Study, Antimicrob. Agents Chemother.6: 853–855 (Dec.) 1974.
7.
TurckM.PetersdorfR. G.: Antimicrobial Therapy, KaganB. M., second edition, p. 16, 1974.
8.
ParryM. F.NeuH. C.: Comparison and Evaluation of Ticarcillin and Carbenicillin Using Disk Diffusion Methods, Antimicrob. Agents Chemother.9: 625–632 (Apr.) 1976.
9.
SutherlandR.: α-Carboxy-3-Thienylmethyl-penicillin (BRL2288) A New Semisynthetic Penicillin: In Vitro Evaluation, Antimicrob. Agents Chemother.10: 390–395, 1970.
10.
NeuH. C.WinshellE. B.: In Vitro Studies of a Semisynthetic Penicillin, 6-[D-(−)-α-Carboxy-3-Thienylacetamide] Penicillinic Acid (BBL 2288), Active Against Pseudomonas, Antimicrob. Agents Chemother.10: 385–389, 1970.
11.
AdlerJ. L.: Susceptibility of Proteus Species and Pseudomonas aeruginosa to Penicillins and Cephalosporins, Antimicrob. Agents Chemother.10: 63–67, 1970.
12.
EickhoffT. C.EhaetJ. M.: Comparative Activity In Vitro Of Ticarcillin, BL-P1654, and Carbenicillin, Antimicrob. Agents Chemother.10: 241–244 (Aug.) 1976.
13.
KalkaniE.MarketosN.: Comparative In Vitro Evaluation of the Effects of Ticarcillin and Carbenicillin upon Pseudomonas aeruginosa, Antimicrob. Agents Chemother.9: 89–90 (Jan.) 1976.
14.
BodeyG. P.DeerhakeB.: In Vitro Studies of α-Carboxy-3-Thienylmethyl Penicillin, A New Semisynthetic Penicillin, Appl. Microbiol.21: 61–65 (Jan.) 1971.
15.
WaldE. R.: BL-P1654, Ticarcillin and Carbenicillin: In Vitro Comparison Alone and in Combination with Gentamicin Against Pseudomonas aeruginosa, Antimicrob. Agents Chemother.7: 336–340 (Mar.) 1975.
16.
ParryM. F.NeuH. C.: Ticarcillin for Treatment of Serious Infections with Gram-Negative Bacteria, J. Infect. Dis.134 (X): 476–485 (Nov.) 1976.
17.
MarksM. I.: Carbenicillin: A Clinical and Laboratory Evaluation, Ann. Intern. Med.73: 179–187 (Aug.) 1970.
18.
NeuH. C.: B-Lactamase Production by Pseudomonas aeruginosa, Antimicrob. Agents Chemother.10: 534–538, 1970.
19.
LegakisN. J.PapavassiliouJ.: In Vitro Activity of Ticarcillin, Carbenicillin, and Ampicillin Against Some Gram-Negative Bacilli, J. Antibiot.28: 912–919 (Nov.) 1975.
20.
KlasterskyJ.: Empiric Therapy for Cancer Patients: Comparative Study of Ticarcillin-Tobramycin, Ticarcillin-Cephalothin, and Cephalothin-Tobramycin, Antimicrob. Agents Chemother.7: 640–645 (May) 1975.
21.
HoffmanT. A.BullockW. E.: Carbenicillin Therapy of Pseudomonas and Other Gram-Negative Bacillary Infections, Ann. Intern. Med.73: 165–171 (Aug.) 1970.
DaviesM.: Interactions of Carbenicillin and Ticarcillin with Gentamicin, Antimicrob. Agents Chemother.7: 431–434 (Apr.) 1975.
25.
WeibertR.: Carbenicillin Inactivation of Aminoglycosides In Patients with Severe Renal Failure, Trans. Am. Soc. Artif. Intern. OrgansVol. XXII: 439–443, 1976.
BodeyG. R.: Infections in Cancer Patients, Concer Treat. Rev.2: 89–128 (Mar.) 1975.
28.
WiseR.: Administration of Ticarcillin, a New Anti-Pseudomonal Antibiotic in Patients Undergoing Dialysis, Antimicrob. Agents Chemother.5: 119–120 (Feb.) 1974.
29.
KlasterskyJ.DaneauD.: Comparison between Carbenicillin and (BRL 2288), A New Semisynthetic Penicillin Active Against Pseudomonas Aeruginosa, Ther. Res.14: 503–509 (Aug.) 1972.
SutherlandR.WiseP. J.: α-Carboxy-3-Thienylmethyl Penicillin (BRL 2288), a New Semisynthetic Penicillin: Absorption and Excretion in Man, Antimicrob. Agents Chemother.10: 402–406, 1970.
33.
NeuH. C.GarveyG.: Comparative in Vitro Activity and Clinical Pharmacology of Ticarcillin and Carbenicillin, Antimicrob. Agents Chemother.8: 457–462 (Oct.) 1975.
34.
ColeM.: Metabolism of Penicillin to Penicillinic Acids and 6-Aminopenicillinic Acid in Man and Its Significance in Assessing Penicillin Absorption, Antimicrob. Agents Chemother.3: 463–468 (Apr.) 1973.
35.
HoffmanT. A.: Pharmacodynamics of Carbenicillin in Hepatic and Renal Failure, Ann. Intern. Med.73: 173–178 (Aug.) 1970.
36.
LatosD. L.: Carbenicillin Therapy in Patients with Normal and Impaired Renal Function, Clin. Pharmacol. Ther.17: 692–700 (Mar.) 1975.
37.
BarzaM.: Extraction of Antibiotics from the Circulation by Liver and Kidney: Effect on Probenicia, J. Infect. Dis.131: 586–597 (May) 1975.
38.
FishmanR. A.: Blood-Brain and CSF Barriers to Penicillin and Related Organic Acids, Arch. Neurol.15: 113–124 (Aug.) 1966.
39.
MacFarlaneD. M.McCarronM. M.: Anaphylactic Shock and Anaphylactoid Reaction, Drug Intell. Clin. Pharm.7: 394–405 (Sept.) 1973.
40.
BrownC. H.III: The Hemostatic Defect Produced by Carbenicillin, N. Engl. J. Med.291: 265–270 (Aug.) 1974.
41.
WaisbredB. A.: Carbenicillin and Bleeding, J. Am. Med. Assoc.217: 1243 (Aug.) 1971.
42.
BrownC. H.III: Study of the Effects of Ticarcillin on Blood Coagulation and Platelet Function, Antimicrob. Agents Chemother.7: 652–657 (May) 1975.
ParryM. F.: Treatment of Pulmonary Infection in Patients with Cystic Fibrosis: A Comparative Study of Ticarcillin and Gentamicin, J. Pediatr.90: 144–148 (Jan.) 1977.